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Abstract 
 
Increased ‘anaerobic’ glucose metabolism is observed after traumatic brain injury (TBI) 
attributed to increased glycolysis. An alternative route is the pentose phosphate pathway 
(PPP), which generates putatively protective and reparative molecules. To compare pathways 
we employed microdialysis to perfuse 1,2-
13
C2 glucose into the brains of 15 TBI patients and 
macroscopically normal brain in 6 patients undergoing surgery for benign tumours, and to 
simultaneously collect products for NMR analysis. 
13
C enrichment for glycolytic 2,3-
13
C2 
lactate was median 5.4% (IQR 4.6-7.5%) in TBI brain and 4.2% (2.4-4.4%) in ‘normal’ brain 
(p<0.01). The ratio of PPP-derived 3-
13
C lactate to glycolytic 2,3-
13
C2 lactate was median 
4.9% (3.6-8.2%) in TBI brain and 6.7% (6.3-8.9%) in ‘normal’ brain. An inverse relationship 
was seen for PPP-glycolytic lactate ratio vs. PbtO2 (r=-0.5, p=0.04) in TBI brain. Thus, 
glycolytic lactate production was significantly greater in TBI than ‘normal’ brain. Several 
TBI patients exhibited PPP-lactate elevation above the ‘normal’ range. There was 
proportionally greater PPP-derived lactate production with decreasing PbtO2. The study raises 
questions about the roles of the PPP and glycolysis after TBI, and whether they can be 
manipulated to achieve a better outcome. This study is the first direct comparison of 
glycolysis and PPP in human brain. 
 
Keywords: 
13
C-labelling, glycolysis, pentose phosphate pathway, lactate, traumatic brain 
injury (human) 
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Introduction 
An increase in the proportion of glucose undergoing ‘anaerobic’ (non-oxygen consuming) 
metabolism is observed after traumatic brain injury (TBI).
1-3
 This has been postulated to 
provide the energy in the form of adenosine triphosphate (ATP), produced via glycolysis, 
needed to restore ionic and neurochemical gradients, which become disturbed after TBI.
4,5
 
Up-regulation of the pentose phosphate pathway (PPP) has also been suggested as a possible 
contributor to increased anaerobic glucose metabolism after TBI, based on rat models, and 
indirect (arteriovenous-jugular difference) studies in human patients.
6-8
 
 
Glycolysis consists of the Embden-Meyerhof pathway from glucose to pyruvate, which does 
not use oxygen, and generates 2 moles of ATP per mole of glucose. Pyruvate can then be 
metabolised via the mitochondrial tricarboxylic acid cycle (TCA) cycle coupled to 
mitochondrial electron transport chains, which utilise oxygen in oxidative phosphorylation. 
The theoretical overall yield is 36 moles of ATP per mole of glucose. Alternatively, pyruvate 
can be converted to lactate, which recycles NADH (reduced nicotinamide-adenine 
dinucleotide) to NAD
+
, enabling further glucose molecules to be processed by glycolysis.  
 
The PPP, also termed the hexose monophosphate shunt, is a biosynthetic pathway that 
constitutes a complex detour bypassing some of the steps of glycolysis in the metabolism of 
glucose. The key enzyme for the PPP, glucose-6-phosphate dehydrogenase, which is 
responsible for the rate-limiting step, is present in most tissues and cell types, and is regarded 
as a “housekeeping” enzyme.
9,10
 The PPP does not consume or produce ATP and does not 
require molecular oxygen. In the early “oxidative phase” of the PPP, during which the first 
carbon of the glucose skeleton is lost as carbon dioxide, nicotinamide adenine dinucleotide 
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phosphate (NADP
+
) is converted to NADPH. The latter is a reducing agent that participates 
in reductive biosynthetic reactions, such as lipid and steroid synthesis, and in the production 
of the reduced form of glutathione and thioredoxin. Glutathione and thioredoxin are cofactors 
for glutathione peroxidase enzymes and peroxiredoxins respectively, both of which scavenge 
hydroperoxides, thereby combatting oxidative stress. Among the many intermediates of the 
later “non-oxidative” phase of the PPP is ribose 5-phosphate, used for nucleic acid synthesis. 
Hence, the proportion of glucose metabolised via the PPP is greatest in tissues with high 
lipid- and steroid-synthetic roles (e.g. liver and lactating mammary glands), also in cells with 
a high oxidative load (e.g. red blood cells), and is thought to be one of the mechanisms 
supporting high cell proliferation rates in cancer.
10
 PPP activity after TBI has been postulated 
as playing a protective role, promoting synthesis of nucleic acids and fatty acids for tissue 
repair and combatting the oxidative stress that results from injured cells.
6,11
 
 
Our aim was to evaluate glycolysis and the PPP as routes of glucose metabolism, directly in 
TBI patients’ brains. Our novel approach was to perfuse the brain using a microdialysis 
catheter with 1,2-
13
C2 glucose and measure the ensuing labelling patterns in lactate collected 
in the emerging microdialysates by analysing them using high-resolution nuclear magnetic 
resonance (NMR) spectroscopy. For comparison, we also carried out the same technique in 
‘normal’ brain, and in muscle as a non-CNS tissue. The present study is the first direct 
comparison of glucose metabolism via glycolysis and PPP in human brain.  
 
Materials and methods 
Patients  
The Cambridge Central Local Research Ethics Committee approved this study. Informed 
consent was obtained from all participants in the control ‘normal’ brain and muscle groups 
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and assent from the relatives of those patients who had suffered a TBI. The study was carried 
out in conformation with the spirit and the letter of the Declaration of Helsinki. 
 
TBI brain microdialysis patients: The TBI patients were defined as those suffering cranial 
trauma with consistent CT scan findings and requiring invasive intracranial monitoring as 
part of their clinical management. Patients were managed according to local TBI-
management protocols, which include endotracheal intubation, ventilation, sedation, and 
muscular paralysis.
12
 
 
Control ‘normal’ brain microdialysis patients: Patients undergoing a craniotomy for the 
resection of a benign lesion whereby a microdialysis catheter could be safely placed into 
radiographically normal brain were selected as control subjects. The microdialysis catheter 
was placed via the craniotomy and tunnelled under the scalp. The control patients were 
awake for the duration of microdialysis perfusion. 
 
Muscle microdialysis patients: Patients undergoing resections of acoustic neuromas that 
required thigh fat and fascia harvesting for dural closure were recruited for studying muscle, 
for comparison with brain. During the procedure to harvest fat and fascia a microdialysis 
catheter was placed under direct vision into quadriceps muscle. The muscle microdialysis 
subjects were under general anaesthesia for the duration of the microdialysis perfusion, which 
was performed at the same time of day for each patient minimising the effect of diurnal 
variation. 
 
Microdialysis technique 
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CMA 71 microdialysis catheters (membrane length 10 mm, nominal molecular weight cut-off 
100 kDa) (M Dialysis AB, Stockholm, Sweden) were placed either via a triple lumen cranial 
access device (Technicam, Newton Abbot, UK) or during a craniotomy for a traumatic 
lesion, along with an intracranial pressure (ICP) monitor (Codman, Raynham, MA, USA) and 
a Licox brain tissue oxygen sensor (GMS, Kiel-Mielkendorf, Germany) into frontal lobe. For 
TBI patients with a diffuse injury, the right frontal region was chosen; if there was greater 
injury to one hemisphere rather than the other, the most injured side was chosen. The catheter 
was not placed within nor immediately adjacent to the lesion itself. CMA 71 catheters were 
used for control ‘normal’ brain subjects and placed via the cranial opening at the end of their 
neurosurgical procedure. CMA 60 catheters (membrane length 30 mm, nominal molecular 
weight cut-off 20 kDa) were used for muscle subjects and placed under direct vision into 
right quadriceps muscle following fat and fascia harvesting under general anaesthesia. 
 
Catheters in the TBI patients and the normal brain control subjects were perfused with CNS 
Perfusion Fluid (M Dialysis, AB), composed of NaCl (147 mmol/L), KCl (2.7 mmol/L), 
CaCl2 (1.2 mmol/L), and MgCl2 (0.85 mmol/L) in water, supplemented with 4 mmol/L 1,2-
13
C2 glucose (see below for details). Muscle microdialysis catheters were perfused with T1 
Perfusion Fluid (M Dialysis AB), composed of NaCl (147 mmol/L), KCl (4 mmol/L), and 
CaCl2 (2.3 mmol/L) in water, supplemented with 4 mmol/L 1,2-
13
C2 glucose. The 
concentration (4 mmol/L) of 
13
C-labelled substrate was chosen to be within the range found 
in brain and muscle microdialysates in unlabelled studies, to minimise perturbation.
13-15
 1,2-
13
C2 glucose (isotopic enrichment 99%, chemical purity 99%) was obtained from Cambridge 
Isotope Laboratories, Inc (Tewksbury, MA) and was formulated in CNS perfusion fluid or T1 
perfusion fluid by the Manufacturing Unit, Department of Pharmacy, Ipswich Hospital NHS 
Trust (Ipswich, UK), who then tested the formulations to verify purity, sterility, freedom 
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from endotoxins and absence of pyrogenicity, to comply with current regulations, before 
releasing them for use in patients. Microdialysate collection vials from the TBI patients were 
changed hourly and analysed at the bedside using an ISCUS analyser (M Dialysis AB) 
employing enzymatic colorimetric assays for glucose, lactate, pyruvate, glutamate and 
glycerol. Microdialysate vials from ‘normal’ brain and from muscle were also analysed with 
the ISCUS analyser at 4- and 2-hourly intervals, respectively. ICP, cerebral perfusion 
pressure, and brain tissue oxygen tension (PbtO2) data from TBI patients were recorded at the 
bedside using ICM+ software (ICM+, University of Cambridge, UK). Microdialysate 
samples were stored at 4°C (or at –80°C if storage for longer than a few days was necessary) 
prior to NMR analysis. 
 
NMR analysis 
Brain microdialysate samples were pooled into 24-hour periods for each individual patient. 
For NMR analysis, 20 µL of deuterium oxide (D2O) and 50 µL internal reference standard 
from a stock solution of 24.0 mmol/L 3-(trimethylsilyl)-1-propanesulfonic acid sodium salt 
(also termed 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt or 4,4-dimethyl-4-
silapentane-1-sulfonate sodium salt; DSS) (Sigma-Aldrich, Poole, Dorset, UK) in CNS 
perfusion fluid (M Dialysis) was added to 180 µL of the pooled microdialysate sample. 
Muscle microdialysate samples were pooled into 8-hour periods. 20 µL of D2O and 70 µL 
from a stock solution of 2.84 mmol/L DSS was added to 120 µL of the pooled microdialysate 
sample. Pooled samples, after addition of D2O and DSS, were stored at −80˚. For NMR 
analysis, samples were transferred into 3 mm NMR tubes (Hilgenberg GmbH, Malsfeld, 
Germany). 
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13
C and 
1
H NMR spectra were acquired on a Bruker Avance III HD 500 MHz spectrometer 
(Bruker BioSpin GmbH, Karlsruhe, Germany) with a dual 
1
H/
13
C cryoprobe (CP 
DUL500C/H, Bruker BioSpin GmbH). 
13
C and 
1
H NMR spectra were acquired and processed 
using TopSpin software (Bruker GmbH). 
1
H spectra were acquired using the pulse 
programme noesypr1d, a 1D NOESY experiment using presaturation to suppress the water 
signal. Acquisition parameters included 32 scans with a d1 (relaxation delay) of 2s. 
13
C 
spectra were acquired using the pulse programme zgpg30, which has 30-degree flip-angle on 
the carbon channel, with a d1 of 3s, using 4096 (4k) scans and digitising 64K points. Power-
gated broadband 
1
H decoupling is achieved using the ‘WALTZ-16’ supercycle. The receiver 
gain is set to a constant value in each experiment. Metabolite signals in the samples were 
identified by comparison of their chemical shifts (ppm, reference DSS) to values from NMR 
databases (BMRB - Biological Magnetic Resonance Bank, University of Wisconsin
16
; 
HMDB - Human Metabolome Database, Genome Alberta
17
) and to those of our own 
standards. To confirm the identity of peaks, in selected cases, 
1
H-
13
C heteronuclear single 
quantum correlation (HSQC) spectra were acquired on standards and patients' microdialysate 
samples.  
 
To enable quantification of the signals in the 
13
C and 
1
H 1-dimensional spectra, calibration 
was carried out with a series of known concentrations of standards including lactate, 3-
13
C 
lactate, glucose, 1,2-
13
C2 glucose, and glutamine (from Sigma-Aldrich and Cambridge 
Isotope Laboratories). These standards were prepared in CNS Perfusion Fluid with the same 
fixed concentration of D2O and DSS as for the preparation of brain microdialysate samples 
(see above) as an internal standard and run under identical NMR conditions to the pooled 
microdialysates.
 
Peak areas for DSS, glucose, lactate and glutamine signals identified on the 
13
C and 
1
H spectra were determined using combined Gaussian and Lorentzian line-shape 
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fitting. Peak areas relative to the DSS internal standard were used with reference to 
calibration curves for each signal derived from standards (see above) of known 
concentrations, which showed linear relationships between peak areas (ratio to DSS internal 
standard) and concentrations. Fractional enrichment (%) is defined as 100 x [
13
C] / ([
13
C] + 
[
12
C]) where square brackets indicate concentrations of the relevant species. [
13
C] was 
determined from the 
13
C NMR spectra and [
12
C] from the 
1
H spectra, using the calibration 
method above. The natural abundance of 
13
C is 1.1% of all carbon atoms, and 
13
C results 
presented for lactate (see Results section) were expressed after subtracting this natural 
background from the 
13
C singlet signals. 
13
C doublet signals were not background-subtracted, 
because the probability of two 
13
C atoms occurring next to each other naturally is 0.01%.  
 
Interpretation of the NMR results was based on biosynthetic pathways summarised 
schematically in Fig. 1, which shows the lactate labelling patterns corresponding to 
glycolysis, which produces 2,3-
13
C2 lactate, and the PPP, which produces 3-
13
C lactate.  
 
Statistical Analysis 
Statistical analyses performed using SPSS21 for Mac (IBM SPSS Statistics, NY) included 
non-parametric tests (Mann-Whitney U-test and Kruskal–Wallis one-way analysis of 
variance) with a preselected p-value of 0.05 for statistical significance. Results are presented 
as median values with the interquartile range (IQR) given in parentheses. Relationships 
between PbtO2 and the 
13
C labelling results were explored using linear regression, with 
Pearson’s correlation coefficient r and analysis of variance (ANOVA) p values.  
 
Results 
Demography 
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Fifteen severe TBI patients (10 M, 5 F) aged 16-59 y (median 27 y) were studied using 1,2-
13
C2 glucose (4 mmol/L) perfusion via the microdialysis catheter, with simultaneous 
collection of microdialysates for NMR analysis.  For comparison, macroscopically normal-
appearing brain was studied using the same 
13
C-labelled microdialysis method in six patients 
(age range 59-73 y; 3 M, 3 F) undergoing surgery for benign brain tumours. For a non-CNS 
tissue comparison, thigh (quadriceps) muscle was similarly studied in four patients (age range 
20-61 y; 3 M, 1 F) who underwent surgery for acoustic neuroma resection. A further seven 
patients (2 ‘normal’ brain, 5 muscle) were studied by microdialysis but with plain 
unsupplemented perfusion fluid without 1,2-
13
C2 glucose. The 15 TBI patients who received 
1,2-
13
C2 glucose (see above) were also studied for a baseline period with plain 
unsupplemented perfusion fluid (without 1,2-
13
C2 glucose). Demographic details of all 
patients are presented in Supplementary Table 1. 
 
Baseline results compared with 1,2-
13
C2 glucose perfusion period 
Microdialysate measurements (using the ISCUS analyser) of glucose, lactate, pyruvate, 
glutamate and glycerol are shown in Fig. 2. These were acquired in the 15 TBI patients 
during periods when the microdialysis catheter was perfused with plain unsupplemented CNS 
perfusion fluid and also during the 24 h period of perfusion with 1,2-
13
C2 glucose (4 
mmol/L). In ‘normal’ brain, ISCUS analysis was performed for two patients who received 
plain unsupplemented perfusion fluid and for six patients who received 24 h perfusion with 
1,2-
13
C2 glucose (4 mmol/L). In muscle, ISCUS analysis was performed for five patients who 
received plain unsupplemented perfusion fluid, and for four patients who received 8 h 
perfusion with 1,2-
13
C2 glucose (4 mmol/L). The 8 h period for muscle was necessitated due 
to clinical practicalities of limb movement - microdialysis was limited to periods during the 
acoustic neuroma surgery.  
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Significant increases (p < 0.05) in microdialysate glucose concentration (measured on the 
ISCUS analyser) between baseline (unsupplemented) and the 1,2-
13
C2 glucose perfusion 
period were seen for all three groups, as follows (medians): TBI brain (from 1.0 to 3.8 
mmol/L), ‘normal’ brain (from 1.9 to 3.9 mmol/L) and muscle (from 2.8 to 5.3 mmol/L). The 
only other statistically significant, but not thought to be biologically significant, changes in 
ISCUS results between baseline and the 1,2-
13
C2 glucose perfusion period were for 
lactate/pyruvate ratio in TBI brain (from 22.2 to 24.8), for glycerol in TBI brain (from 52.0 to 
69.6 µmol/L), and for glutamate in TBI brain (from 3.4 to 4.4 µmol/L) and muscle (from 7.9 
to 29.7 µmol/L). Concentrations of 1,2-
13
C2 glucose (median and IQR) measured by 
13
C 
NMR in the microdialysates from TBI brain (24 h perfusion period), normal brain (24 h 
perfusion period) and muscle (8 h perfusion period) were respectively 2.14 (1.45-2.43), 
0.93 (0.83-1.83) and 0.95 (0.59-1.25) mmol/L, with TBI significantly different from normal 
brain (p = 0.008) or muscle (p = 0.016). 
 
Throughout the 24 h period during which the cerebral microdialysis catheter was 
perfused with 1,2-
13
C2 glucose, the median serum glucose concentration measured in 
TBI patients was 7.3 mmol/L and all values were within the range 4-12 mmol/L except 
for one time-point in patient 11 where glucose was 1 mmol/L. Median serum lactate 
concentration was 1.1 mmol/L (min 0.7, max 3.0 mmol/L). (Supplementary Fig. 1). 
 
NMR results for lactate production by glycolysis and PPP, and relationship with 
brain tissue oxygen 
Illustrative examples of 
13
C NMR spectra of the microdialysates are shown in Fig. 3. As a 
result of 1,2-
13
C2 glucose perfusion, TBI brain and ‘normal’ brain microdialysates included a 
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clearly visible doublet (red stars in expansion of 
13
C spectra) for the lactate C3 methyl group, 
and likewise a doublet for lactate C2, indicating glycolysis-derived 2,3-
13
C2 lactate, and a 
smaller C3 singlet (green stars in expansion of 
13
C spectra) representing PPP-derived 3-
13
C 
lactate plus endogenous lactate. Qualitatively similar-appearing spectra were seen for muscle 
microdialysates resulting from 1,2-
13
C2 glucose perfusion. Unlabelled TBI microdialysates 
(with plain unsupplemented perfusion fluid) showed singlets for endogenous lactate C3 and 
C2 (Fig. 3).  
 
Natural abundance of 
13
C was assumed 1.1%, and 
13
C fractional enrichment values for lactate 
were expressed after subtracting this naturally occurring 
13
C background from the 
13
C singlet 
signals. In TBI brain microdialysates, 
13
C fractional enrichment (%) in 2,3-
13
C2 lactate, 
indicative of glycolysis, was median 5.4% (IQR 4.6-7.5%) measured using the C3 doublet 
and this was significantly greater than in ‘normal’ brain (Fig. 4). Fractional enrichment was 
based on quantification of the lactate C3 doublet signal (
13
C spectrum) to measure 
13
C at the 
C3 position and the lactate methyl protons (attached to C3) triplet signal (
1
H spectrum) to 
quantify 
12
C at the C3 position. Similar 
13
C fractional enrichment to that of lactate C3 doublet 
was obtained using the lactate C2 doublet, as expected (Fig. 4). In muscle, 
13
C fractional 
enrichment in 2,3-
13
C2 lactate was lower than in TBI and ‘normal’ brain (Fig. 4). 
 
Based on the lactate C3 methyl group, 
13
C fractional enrichment (%) in 3-
13
C lactate 
indicative of the PPP in TBI brain microdialysates was median 0.24% (IQR 0.17-0.61%) 
(Fig. 4) which was thus much less than the 
13
C fractional enrichment in glycolytic 2,3-
13
C2 
lactate (above). The ratio in TBI brain microdialysates of PPP-derived 3-
13
C lactate to 
glycolytic 2,3-
13
C2 lactate was median 4.9% (IQR 3.6-8.2%) (Fig. 4). Four of the 15 TBI 
patients exhibited ratios of PPP-derived to glycolytic lactate (11.4, 11.5, 11.9 and 14.0%) that 
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were greater than the range observed in the present study in normal brain (min 5.9, max 
10.4%). 
 
In muscle, microdialysis perfusion with 1,2-
13
C2 glucose (4 mmol/L, for 8 h) resulted in 
lactate C3 doublet and C2 doublet, indicating glycolytic 2,3-
13
C2 lactate, with 
13
C enrichment 
at C3 median 1.2% (range 1.0-1.4%). However, there was no 
13
C enrichment above 
background natural abundance for lactate C3 singlet, so PPP production of lactate was not 
detected in muscle.  
 
The concentration of 2,3-
13
C2 lactate (indicative of glycolysis) showed a non-significant 
inverse trend (r = -0.4, p = 0.1) with brain tissue oxygen concentrations (PbtO2 expressed in 
mm Hg) measured in the vicinity of the microdialysis catheter in TBI brain. A significant 
inverse correlation (r = -0.5, p = 0.04) was seen for the ratio of PPP-lactate to glycolytic 
lactate vs. PbtO2 (Fig. 5). Local tissue oxygen concentration was not measured in normal 
brain or muscle. 
 
Five TBI patients had a second 24 h period of 1,2-
13
C2 glucose (4 mmol/L) microdialysis 
perfusion. There were no significant differences in the production of glycolytic-lactate or 
PPP-derived lactate between these two time periods.  
 
Discussion 
This study has shown that 1,2-
13
C2 glucose infusion via the microdialysis catheter results in 
13
C-labelling in lactate (Fig. 3) in the emerging microdialysates, enabling us to compare 
glycolysis and PPP as routes by which lactate is derived. This is the first time this comparison 
has been performed directly in human brain.  
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Glucose metabolism via glycolysis and the pentose phosphate pathway  
Clear evidence for glycolysis being the main route of lactate production from glucose, as 
expected, was seen as diagnostic doublet signals for both C3 and C2 of lactate (Fig. 3) 
indicating 2,3-
13
C2 lactate, a hallmark of the pathway (Fig. 1). These doublets were seen for 
all patients, in TBI brain, ‘normal’ brain and muscle.  This is in accord with the recognised 
glycolysis pathway consisting of the Embden-Meyerhof pathway from glucose to pyruvate, 
followed by conversion to lactate by the action of lactate dehydrogenase (Fig. 1). This 
13
C 
enrichment was significantly higher in TBI brain, suggesting greater glycolytic activity, than 
in ‘normal’ brain and muscle. The doublet signals provide a distinctive signature that in effect 
avoids the issue of natural abundance 
13
C background (1% of all carbon atoms), since the 
probability of two endogenous 
13
C atoms occurring next to each other naturally is 0.01%.  
 
The PPP loses the first carbon of 1,2-
13
C2 glucose as carbon dioxide and thus gives rise to 3-
13
C lactate with a singlet signal for C3 (Fig 1). While 
13
C singlet signals for lactate C3 were 
clearly visible in all patients’ microdialysates (Fig 3), these were smaller than the C3 doublet. 
Furthermore, it emerged that much of the C3 singlet signal intensity (peak area) was due to 
endogenous natural abundance 
13
C.  Small 
13
C fractional enrichments for lactate C3 singlet 
above this background were seen in microdialysates from TBI brain and ‘normal’ brain, 
indicating PPP-derived lactate, but negligible in muscle. While there was no statistically 
significant difference in 
13
C fractional enrichment for lactate C3 between ‘normal’ brain and 
TBI brain, the higher upper range of the latter suggests that in certain TBI individuals lactate 
production via the PPP is elevated above that in ‘normal’ brain. In the four TBI patients with 
the most elevated PPP lactate, the ratio (%) of PPP lactate to glycolytic lactate was 11.4 – 
14.0%. 
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Our finding of increased PPP activity in some patients as a result of brain injury is supported 
by experimental studies. In rat models relevant to TBI, Bartnik et al. infused 1,2-
13
C2 glucose 
intravenously after fluid percussion injury and cortical contusion injury, and performed NMR 
analysis of brain tissue extracts.  They found an increase in the proportion of 3-
13
C lactate 
(indicative of PPP) relative to 2,3-
13
C2 lactate (indicative of glycolysis), in brain-injured rats 
compared to control rats though with glycolysis remaining dominant.
6,7
 In humans, Dusick et 
al. infused 1,2-
13
C2 glucose intravenously, with 
13
C labelling in lactate assessed by 
arteriovenous-jugular difference.
8
 This study in TBI patients and controls, although it did not 
sample the brain directly and could only yield information on brain lactate labelling during 
periods when the brain was a net exporter of lactate into the vasculature, led to similar 
conclusions to the rat studies above.  
 
Significance of the PPP 
The PPP is a complex biosynthetic network generating many other species besides lactate 
(Fig. 1) and the balance between these species can potentially shift depending on the local 
biology and pathology. Some PPP-derived species are potentially reparative, e.g. ribose (for 
nucleic acid synthesis) and NADPH (to provide reducing equivalents for fatty acid synthesis), 
and neuroprotective e.g. NADPH, used for producing the reduced form of glutathione and 
thioredoxin, which are cofactors for glutathione peroxidases and peroxiredoxins respectively, 
enzymes that combat oxidative stress. Accordingly, Herrero-Mendez et al. (2009) 
demonstrated that If one of the key regulatory enzymes of glycolysis, phosphofructokinase, is 
activated in neurons so that more glucose is funnelled through glycolysis at the expense of 
the PPP, apoptosis soon ensues due to oxidative stress.
18
 The PPP, which does not involve 
molecular oxygen and does not generate ATP, can thus be regarded as sacrificing some of the 
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cells’ supply of glucose molecules, which might otherwise have been used for ATP synthesis 
via glycolysis and the TCA cycle, for the sake of generating more reducing power (NADPH) 
and the ability to protect, repair or build cells.  
 
NADPH is involved in many other biochemical reactions, e.g. NADPH is a cofactor for 
NADPH oxidase and nitric oxide synthase and if these become dysregulated, oxidative stress 
may ensue, with adverse consequences. Zuurbier et al. (2004) reported that inhibition of the 
so-called “oxidative” phase of the PPP (the early steps of the PPP responsible for NADPH 
production), by means of administering 6-aminonicotinamide, was cardioprotective in an 
ischemia-reperfusion rat heart model.
19
 Interestingly, when Tyson et al. (2000) administered 
6-aminonicotinamide to inhibit the PPP in rats in a study of brain using intravenous 2-
13
C 
glucose as the substrate, they found that despite achieving PPP inhibition, evidenced by a 
build-up of 6-phosphogluconate, there appeared to be a feedback effect of PPP inhibition on 
glycolysis, such that both pathways decreased in a constant ratio.
20
 
 
Role of brain tissue oxygen concentration in brain metabolism 
In the literature, ‘hyperglycolysis’ and the elevation of lactate production in the injured brain 
have been attributed to hypoxia and/or mitochondrial dysfunction, though the exact nature of 
the latter remains unclear. In a combined positron emission tomography (PET) (oxygen-15 
and fluorodeoxyglucose (18F)) and microdialysis study, Vespa et al. (2005) reported that 
‘metabolic crisis’ (defined as lactate/pyruvate ratio > 40) occurred in 7 out of 19 TBI patients 
studied, though only one case showed regional ischaemia judged by PET.
2
 In a microdialysis 
study of 24 TBI patients in conjunction with PbtO2 measurement and perfusion CT, Sala et al. 
(2013) concluded that the majority of lactate production was ‘glycolytic’ (rather than 
hypoxic), albeit without evidence from carbon labelling.
21
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In the present study, we measured PbtO2 alongside the microdialysis catheter in the TBI 
patients, and found that there was a non-significant trend towards greater glycolytically 
generated 2,3-
13
C2 lactate with decreasing PbtO2. It is important to note that there were only 3 
cases that could be described as hypoxic (defined as PbtO2 < 20 mm Hg), and the remaining 
14 data-points ranged from 22 to 43 mm Hg. Interestingly, the ratio of PPP-derived lactate to 
glycolytic lactate showed a significant inverse correlation with PbtO2 (r= -0.5, p = 0.04) (Fig 
5). Thus, although PPP-derived lactate was always much less than glycolytic lactate, the 
balance between the two appeared to shift towards the PPP with lower PbtO2. Like glycolysis, 
the PPP does not utilise oxygen. Studies in adult rats and in brain slices have also suggested 
that hypoxia increases the PPP.
22
 In contrast, Brekke et al. (2014) found evidence for a 
decrease in PPP in neonatal rats after hypoxic-ischaemic injury, which the authors discussed 
as paradoxical.
23
 Moreover, they postulated that the apparent inability to up-regulate the PPP 
in this situation might render the neonatal rats vulnerable. An analogous situation might 
conceivably exist in human TBI, whereby low ability to up-regulate the PPP might result in 
those individuals’ brain tissue (either globally or locally) having increased risk of damage. 
Therapeutic up-regulation of the PPP in this context might be beneficial. Apart from 
hypoxia (mentioned above), a few other up-regulators of the PPP have been identified. 
Insulin has been shown to increase the expression of glucose-6-phosphate 
dehydrogenase mRNA in primary rat hepatocytes.
24
 Dehydroascorbate, the oxidised 
form of vitamin C, has been shown to stimulate the activity of several PPP enzymes, 
increase glutathione levels and inhibit hydrogen peroxide-induced changes in 
mitochondrial transmembrane potential in Jurkat cells (a cancer cell line).
25
 Although 
these two latter studies were not performed in brain, they nevertheless illustrate the 
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principle that the PPP can be deliberately up-regulated with measurable biochemical 
and biological effects. 
 
Significance of lactate in the brain 
Lactate has been conventionally regarded as a waste product of glucose metabolism, though a 
more recent idea is that it can act as a brain fuel - neurons take up lactate (produced from 
glucose by glia), metabolise lactate to pyruvate, which is transported into the mitochondria 
and converted to acetyl CoA, which enters the tricarboxylic acid (TCA) cycle. This has 
become known as the astrocyte-neuron lactate shuttle hypothesis.
26
 Animal studies have 
provided evidence for brain utilisation of intravenously administered 3-
13
C lactate via the 
TCA cycle.
27
 In human brain, direct evidence for utilisation of lactate was first obtained in a 
cerebral microdialysis study in TBI patients.
28
 In the latter study, administration of 3-
13
C 
lactate via the microdialysis catheter, and simultaneous collection of the emerging 
microdialysates, with 
13
C NMR analysis, revealed 
13
C labelling in glutamine consistent with 
lactate utilisation via the TCA cycle.
28
 Recently, an intravenous lactate supplementation 
study in TBI patients revealed evidence for a ben ficial effect judged by surrogate 
endpoints.
29
 Studies of brain microdialysates (without supplementation) in 223 patients show 
a statistical association between high extracellular lactate and unfavourable outcome.
30
 Taken 
together, available evidence suggests that where neurons are too damaged to utilise the 
lactate produced from glucose by astrocytes, i.e. uncoupling of neuronal and glial 
metabolism, high extracellular levels of lactate would accumulate, explaining one potential 
mechanism behind the association between high extracellular lactate and poor outcome. 
 
Fate of lactate 
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Regarding the possible fate of labelled lactate produced from 1,2-
13
C2 glucose, a likely 
scenario is that some of the labelled lactate is processed via the TCA cycle, and some of it 
exported into the bloodstream. Since we were micro-dosing the brain with 1,2-
13
C2 glucose 
locally via the microdialysis catheter, it seemed highly unlikely that any of the ensuing 
doubly labelled lactate would have been detectable in the bloodstream given the inevitable 
dilution both with endogenous unlabelled lactate and with the volume of blood, so 
13
C NMR 
analyses of blood were not performed. 
 
Previously, using 3-
13
C lactate as the substrate, we detected singly labelled glutamine (and/or 
glutamate) in TBI brain microdialysates, indicating utilisation of lactate via the TCA cycle.
28
 
In the present study, if 2,3-
13
C2 lactate (produced from the substrate 1,2-
13
C2 glucose) entered 
the TCA cycle in brain cells, this would in theory have resulted in doublets in the 
13
C NMR 
spectra, due to 4,5-
13
C2 glutamine and 2,3-
13
C2 glutamine (and/or glutamate in each case) on 
the first turn of the cycle, and, on the second turn, doublets due to 1,2
13
C2 glutamine and a 
singlet due to 3-
13
C glutamine.
23,31
 Experimental models of brain injury in rodents, using 1,2-
13
C2 glucose as substrate, with analysis of brain tissue extracts representing total intracellular 
and extracellular molecules, confirm double labelling in glutamate and glutamine.
6,7,31
 In our 
present study, small singlet signals, but not doublets, corresponding to glutamine were seen 
in the 
13
C NMR spectra of some of the microdialysates from ‘normal’ brain (4/6 patients) and 
TBI (2/15 patients), verified by 2-D NMR methods, including 
1
H-
13
C HSQC (Supplementary 
Fig. 2). In theory, pyruvate cycling,
32
 which breaks the 
13
C-
13
C bond might explain the 
glutamine singlets. Also, in theory, PPP-derived 3-
13
C lactate might enter the TCA cycle 
forming singly-labelled glutamine (and/or glutamate), although accompanied by doubly-
labelled glutamine from glycolytic 2,3-
13
C2 lactate, as found in vitro by Brekke et al. 
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(2012).
33
 However, in the present study, quantification of the small glutamine singlets 
revealed no significant 
13
C enrichment above natural abundance.  
  
Microdialysis only samples the extracellular compartment and therefore cannot measure the 
intracellular distribution of 
13
C. Even so, our 
13
C-labelled microdialysis method provides a 
useful means for measuring ‘early’ glucose metabolism (glycolysis and PPP) as sufficient 
labelled lactate is exported into the extracellular compartment to allow detection. However, 
in the subsequent metabolism of lactate, the downstream dilution of 
13
C label with 
endogenous unlabelled intermediates probably explains why we did not observe significant 
13
C enrichment of extracellular metabolites derived from the TCA cycle. In our previous 
study, when 3-
13
C lactate (4 mmol/L) or 2-
13
C acetate (4 mmol/L) was perfused via the 
microdialysis catheter in TBI brain, labelling in glutamine consistent with TCA cycle was 
seen in the emerging microdialysates.
28
 However, in the same study, perfusion with 1-
13
C 
glucose (2 mmol/L) resulted in negligible labelling in glutamine, consistent with the present 
study.  
 
Strengths and limitations 
This 
13
C-labelled microdialysis method, performed in parallel with local brain tissue oxygen 
measurement, provides a method of measuring glycolytic conversion of glucose into lactate 
and at the same time distinguishing hypoxic from non-hypoxic glycolysis, as well as 
evaluating the contribution of the PPP. Even though our evidence indicates a minor PPP-
derived lactate (3-
13
C lactate), it must be remembered that the PPP is a complex network of 
biosynthetic reactions (Fig. 1) and it is conceivable that if heavy recycling is operating within 
the PPP, less lactate might emerge, though with elevated production of NADPH and 
intermediates utilised in neuroprotection and repair of cells. 
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The strategy of double labelling (using 1,2-
13
C2 glucose as substrate) provides a characteristic 
signature that appears in glycolytic lactate (2,3-
13
C2 lactate) showing that the 
13
C-
13
C 
covalent bond stays intact. Moreover the doublet signal is essentially free from endogenous 
lactate as the probability of two 
13
C atoms being adjacent to each other naturally is 0.01%. 
Like all cerebral microdialysis the 
13
C-labelled microdialysis method is invasive, so is only 
suitable for severe TBI patients or those requiring brain surgery (e.g. for tumours), and it is a 
focal technique.  
 
This 
13
C-labelling method has the potential to be a useful adjunct to existing methodologies 
of PET and unlabelled microdialysis in monitoring and studying TBI patients. The 
13
C-
labelled microdialysis method does not involve disruption of the patient’s standard medical 
care on the neurocritical care unit, and does not involve radioactivity or moving the patient to 
a scanner. The 1,2-
13
C2 glucose microdialysis method is reasonably inexpensive and 
convenient to perform, since 1 or 2 g of the labelled material are enough to formulate enough 
perfusion fluid for multiple patients, and the formulation can be stored in individual sterile 
ready-to-use sealed glass vials in a refrigerator. The concentration (4 mmol/L) of 1,2-
13
C2 
glucose administered via microdialysis locally into brain corresponds to the upper end of the 
‘normal’ range found in brain ECF.
13
 While conventional microdialysis performed with 
unsupplemented perfusion fluid allows us to measure endogenous extracellular lactate, the 
unsupplemented method cannot inherently distinguish between ‘old’ lactate and recently 
synthesised lactate.  An advantage of the 1,2-
13
C2 glucose microdialysis method is that 
enables measurement of labelled lactate production within a known timeframe – at present 
this is 24h, because of current practical NMR considerations (see below). 
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A current limitation to our 
13
C-labelled microdialysis method is the amount of material 
necessary for performing NMR analysis. We have combined brain microdialysates for a 24h 
period for each patient, to facilitate 
13
C NMR spectroscopy within a convenient acquisition 
time on the spectrometer. Our Bruker Avance 500 MHz spectrometer is equipped with a 
cryoprobe, as used in the present study and in our previous study,
28
 which is more sensitive 
than non-cryo probe technology. Even so, the practical limit with our present equipment 
limits us in terms of how short a timeframe we can analyse in terms of microdialysis 
perfusion. Having better time-resolution for the microdialysis labelling results would be 
useful from a biochemical perspective allowing time-course evaluation. 1,2-
13
C2 glucose 
microdialysis may have future potential for metabolic kinetic modelling of local glucose 
consumption rates and glycolytic- and PPP- production rates of lactate.  Commercially 
available NMR micro-cryoprobes, which take smaller volumes, may be useful in future. 
Analysis by mass spectrometry might also be useful in future, enabling smaller volumes to be 
analysed, though at the expense of at least some of the detailed information on precise intra-
molecular position of label. 
 
Conclusion 
Here we have shown that 
13
C labelled microdialysis can be used to interrogate glucose 
metabolism via glycolysis and the PPP. The major pathway, glycolytic lactate production, 
was significantly greater in TBI brain than in normal brain. The minor pathway, PPP-derived 
lactate production, was statistically not significantly different in TBI brain than in normal 
brain. However, several of the TBI individuals showed PPP-derived lactate elevation above 
the range observed in normal brain. There was a shift in glucose metabolism from glycolysis 
to PPP with decreasing brain tissue oxygen concentrations. The findings raise interesting 
questions about the roles of the PPP and glycolysis after TBI, and whether they can be 
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manipulated to enhance the potentially reparative and antioxidant role of the PPP and 
achieve a better outcome for the patient. The 
13
C methodology developed here provides a 
means of distinguishing recently synthesised lactate and its biosynthetic origin, and at the 
same time measuring local oxygen tension alongside. 
13
C-labelled microdialysis with 1,2-
13
C2 glucose as substrate may thus find a methodological role in studies of hyperoxia or 
strategies to optimise perfusion and mitochondrial function. This is the first time that a 
comparison between glycolysis and the PPP has been carried out directly in human brain. 
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Titles and legends to figures 
Fig. 1. Simplified schematic of steps in glycolysis and the pentose phosphate pathway (PPP), 
showing 
13
C labelling patterns resulting from 1,2-
13
C2 glucose substrate. Red fills indicate 
13
C atoms. Abbreviations: Glc-6-P, glucose-6-phosphate; 6PGL, 6-phosphogluconolactone; 
F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-phosphate; PYR, pyruvate. Figure 
originally published in Eur J Pharm Sci 2014; 57: 87-97 (Carpenter KLH et al.) under a 
Creative Commons Attribution License.
34
 
 
Fig. 2. ISCUS clinical microdialysis analyser measurements: at baseline (light grey bars) 
with plain unsupplemented perfusion fluid and during 24 h perfusion (brain: TBI or normal) 
or 8 h perfusion (muscle) with 1,2-
13
C2 glucose (4 mmol/L) (dark grey bars). LPR is the 
lactate/pyruvate ratio. *p < 0.05 (Mann-Whitney) for baseline vs. perfusion with 1,2-
13
C2 
glucose. Box and whisker plots represent pooled data. Numbers of patients with baseline 
(unsupplemented) measurements were 15 TBI, 2 ‘normal’ brain and 5 muscle. Numbers of 
patients who received 1,2-
13
C2 glucose were 15 TBI, 6 ‘normal’ brain and 4 muscle. 
‘Normal’ brain was macroscopically normal-appearing brain in patients who underwent 
surgery for benign brain tumours. Muscle was leg quadriceps in patients undergoing acoustic 
neuroma resection surgery. 
 
Fig. 3.  Illustrative examples of 
13
C NMR spectra for microdialysates from patients who 
received perfusion with 1,2-
13
C2 glucose (4 mmol/L): TBI brain (uppermost two spectra, 24 h 
perfusion), ‘normal’ brain (third spectrum, 24 h perfusion), and muscle (bottom spectrum, 8 h 
perfusion). An example of brain microdialysate from an unlabelled TBI patient with plain 
(unsupplemented) perfusion fluid is shown for comparison (fourth spectrum). Examples of 
expansion of the lactate C3 signal are shown for TBI brain and ‘normal’ brain. Red stars 
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indicate lactate C3 doublet (due to glycolytic 2,3-
13
C2 lactate) and green stars indicate C3 
singlet (due to pentose phosphate pathway-derived 3-
13
C lactate plus endogenous lactate). 
Abbreviations: glucose (Glc), lactate (Lac), 4,4-dimethyl-4-silapentane-1-sulfonate sodium 
salt (DSS, the internal reference standard). Spectra were run from –20 ppm to +250 ppm. The 
main reference DSS signal at 0 ppm is not shown in the range illustrated. 
 
Fig. 4. Microdialysate NMR measurements of 
13
C labelling: results from perfusion for 24 h 
(brain: TBI or ‘normal’) or 8 h perfusion (muscle) with 1,2-
13
C2 glucose (4 mmol/L). Red 
asterisks denote p < 0.01 for TBI vs. ‘normal’ brain (Mann-Whitney); other comparisons 
asterisked in black denote p < 0.05. Individual data-points are shown by x symbols. Number 
of patients: 15 TBI, 6 ‘normal’ brain, 4 muscle.  
 
Fig. 5. Relationships in TBI brain for glycolytic lactate and pentose phosphate pathway 
(PPP)-derived lactate vs. PbtO2. Concentrations of glycolytic 2,3-
13
C2 lactate (upper panel) 
and PPP-derived 3-
13
C lactate (middle panel) plotted vs. PbtO2. Lower panel: ratio (%) of 
PPP-derived 3-
13
C lactate to glycolytic 2,3-
13
C2 lactate, plotted vs. PbtO2.  Each data-point 
represents the results of NMR analysis of the combined contents of 24 x 1 h of 
microdialysate collection vials from one microdialysis catheter, plotted against the 
corresponding PbtO2 concentration expressed in mm Hg, measured using a Licox oxygen 
probe placed alongside the microdialysis catheter in the brain. Lines are fitted by linear 
regression (statistics shown are Pearson’s correlation coefficient r and ANOVA p value). 
Data are from 13 TBI patients. Four of these 13 had a second period of monitoring, making 
17 data-points in total for each correlation. 
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